Effects of inulin on intestinal flora and metabolism-related indicators in obese polycystic ovary syndrome patients/Experiment 1

From BugSigDB


Needs review

Curated date: 2025/08/04

Curator: Victoria

Revision editor(s): Victoria, Ese

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Obesity Adiposis,Adiposity,Obese,Obese (finding),obesity,Obesity (disorder),Obesity [Ambiguous],obesity disease,obesity disorder,Obesity NOS,Obesity, unspecified,Overweight and obesity,Obesity
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Non-obese control group (NSD)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Obese control group (NFD)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of obese patients with ≥ 25 kg/m2 body mass index (BMI).
Group 0 sample size Number of subjects in the control (unexposed) group
20
Group 1 sample size Number of subjects in the case (exposed) group
16
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2


Signature 1

Needs review

Curated date: 2025/08/04

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 3E

Description: Analysis of Biomarkers with significant differences between groups based on LDA Effect Size.

Abundance in Group 1: increased abundance in Obese control group (NFD)

NCBI Quality ControlLinks
Allisonella
Parabacteroides distasonis
Howardella
[Ruminococcus] torques
Actinomyces massiliensis
TM7 phylum sp. oral clone FR058
Megamonas

Revision editor(s): Victoria

Signature 2

Needs review

Curated date: 2025/08/04

Curator: Victoria

Revision editor(s): Victoria

Source: Figure 3E

Description: Analysis of Biomarkers with significant differences between groups based on LDA Effect Size.

Abundance in Group 1: decreased abundance in Obese control group (NFD)

NCBI Quality ControlLinks
Phocaeicola plebeius
unclassified Oscillospiraceae
Coprococcus eutactus

Revision editor(s): Victoria